Polyendocrine Metabolic Ovarian Syndrome (PMOS) previously known as Polycystic Ovarian Syndrome (PCOS)

Warning

Who to refer

Consider routine referral if there is diagnostic uncertainty after initial assessment (unable to confirm 2 of 3 features).

Urgently

Presentation suggestive of androgen secreting tumour or non-classical Congenital Adrenal Hyperplasia (NC-CAH) or also known as late onset CAH.

  • Rapid virilisation (rapid onset: deepening voice, clitoromegaly, severe hirsutism, reduced breast size, increased muscle bulk)

  • Very high serum testosterone (> ~5 nmol/L or >2× upper limit of normal)

  • Suspected androgen-secreting ovarian/adrenal tumour on examination or imaging.

Who not to refer

  • Fertility difficulty –refer to fertility services

  • Menstrual problems –refer to gynaecology

  • Severe acne and/or problematic hirsutism –refer to dermatology

  • Obesity – refer to weight management services

How to refer

Referral to Endocrinology is via SCI-gateway


Specialty Description

Polycystic Ovarian Syndrome

Polycystic ovarian syndrome (PCOS) is a common hormonal disorder in which there are higher than normal androgen levels which can lead to irregular menstrual periods, abnormal ovulation, infertility, excess facial or body hair and/or acne in women. It is often characterised by insulin resistance.

Diagnose PCOS in adults using the revised evidence-based Rotterdam approach (need 2 of 3):

  • Clinical/biochemical hyperandrogenism (see links below)

  • Ovulatory dysfunction

  • Polycystic ovarian morphology on ultrasound or elevated Anti-Mullerian Hormone) AMH


Primary Care Investigations

Investigations GPs should perform before referral (tailor to presentation):

  • Full history & exam: menstrual history, fertility desires, hair growth, acne, weight/BMI, BP, signs of virilisation.

  • Metabolic screening: fasting glucose or HbA1c; consider fasting lipids; BMI and BP

  • Hormones: total testosterone, FSH, LH, SHBG, TSH, prolactin.

  • Other tests: consider liver function tests; pregnancy test and fertility counselling if relevant.

Ultrasound: in adults, pelvic ultrasound (transvaginal or transabdominal)— but if clinical hyperandrogenism + irregular cycles are present, ultrasound is not required to make the diagnosis


Useful resources

Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome | European Journal of Endocrinology | Oxford Academic

https://cks.nice.org.uk/topics/polycystic-ovary-syndrome/diagnosis/investigations/

Polycystic ovary syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice

Editorial Information

Last reviewed: 11/08/2026

Next review date: 11/08/2028

Reviewer name(s): Catriona Farrell - catriona.farrell@nhs.scot.